EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Techniques in the Treatment of Conjunctival Melanoma

Wendy J Li, Nandini Venkateswaran, Michael Antonietti, Sana Qureshi, Anat Galor, Carol L Karp

Current Ophthalmology Reports · 13.06.2025 · 13 (1)

DOI: 10.1007/s40135-025-00334-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Ophthalmology Reports, online erschienen am 13.06.2025. Verfasst von Wendy J Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Bascom Palmer Eye Institute, 900 NW 17 thStreet, Miami, FL 33136 USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 181 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of review In this article, we summarize the pathogenesis, diagnostic challenges, current management, and emerging therapeutic strategies for conjunctival melanoma (CM). Recent findings CM is a deadly disease with rising global incidence. Key mutations, including BRAF, NF1, and TERT, play crucial roles in CM pathogenesis and may serve as targets for therapy. Advanced imaging and histopathological analysis have improved early detection and prognostic assessment. Treatment depends on tumor stage and includes surgical excision with adjuvant chemotherapy, radiotherapy, or orbital exenteration in advanced cases. Systemic workup is always indicated. Immune checkpoint inhibitors, successful in cutaneous melanoma, show promise in CM based off early studies, although more research is needed to confirm their benefit. Summary CM remains a significant clinical challenge and requires a multidisciplinary approach to diagnosis and treatment. Incorporating genetic profiling and targeted therapies is crucial to improving patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

BrachytherapyConjunctival melanomaImmunotherapyMelanocytic lesionsPrimary acquired melanosisSurgical excision

Autor:innen und Institutionen

  • Department of Ophthalmology, Bascom Palmer Eye Institute, 900 NW 17 thStreet, Miami, FL 33136 USA.
  • Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, MA USA.
  • Department of Ophthalmology, Miami Veterans Hospital, Miami, FL USA.

Förderung

  • Department of Veterans Affairs
  • Veterans Health Administration
  • Office of Research and Development
  • Biomedical Laboratory R&D (BLRD) Service I01
  • Clinical Sciences R&D (CSRD) I01
  • Department of Defense Gulf War Illness Research Program
  • Vision Research Program
  • National Eye Institute

Zitieren

APA

Li, W. J., Venkateswaran, N., Antonietti, M., Qureshi, S., Galor, A., & Karp, C. L. (2025). Emerging Techniques in the Treatment of Conjunctival Melanoma. Current Ophthalmology Reports, 13(1). https://doi.org/10.1007/s40135-025-00334-9

Vancouver

Li WJ, Venkateswaran N, Antonietti M, Qureshi S, Galor A, Karp CL. Emerging Techniques in the Treatment of Conjunctival Melanoma. Current Ophthalmology Reports. 2025;13(1). doi:10.1007/s40135-025-00334-9

BibTeX
@article{Li2025,
  author = {Li, Wendy J and Venkateswaran, Nandini and Antonietti, Michael and Qureshi, Sana and Galor, Anat and Karp, Carol L},
  title = {Emerging Techniques in the Treatment of Conjunctival Melanoma},
  journal = {Current Ophthalmology Reports},
  year = {2025},
  volume = {13},
  number = {1},
  doi = {10.1007/s40135-025-00334-9}
}
Kostenlos starten →